STARTING IN 30 MINUTES: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts

Research evidence excerpt

STARTING IN 30 MINUTES: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts

pective Representatives make any representation

or warranty regarding, accuracy or completeness of any information contained therein

or otherwise. Neither Guggenheim nor any other Presenter nor any of their respective

Representatives shall be liable to any person in any way whatsoever for any losses, costs

or claims for reliance on the materials. Guggenheim and/or any other Presenter may have a

business relationship with certain attendees and/or issuers mentioned during the event or in

any materials provided, or may otherwise underwrite, hold a position, buy or sell as principal

in the securities of any issuer mentioned. Guggenheim may have in the past provided, may

currently be providing and may in the future seek to provide investment banking, financial

advisory and other services to, and have other material relationships with, attendees and/

or issuers of securities, loans and other financial instruments discussed during the event or

referred to in any materials. With respect to any position Guggenheim or any Presenter may

hold, Guggenheim or such Presenter may have interests different from or adverse to your

interests. None of the materials provided may be reproduced or redistributed, in whole or in

part, to any other person or published in whole or in part for any purpose absent the written

consent of Guggenheim. By registering for and/or attending the event and/or accepting

delivery of the materials, you will be deemed to acknowledge and agree to the matters set

forth above. Copyright 2026 by Guggenheim Securities, LLC, a FINRA registered broker-

dealer. All rights reserved. Invitation is non-transferable.